• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Quinazolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazanaphthalenes Benzodiazines Quinazolines

Comprehensive Overview of 7-Bromo-2,5-dichloroquinazolin-8-ol (CAS No. 953039-87-7): Properties, Applications, and Research Insights

7-Bromo-2,5-dichloroquinazolin-8-ol (CAS No. 953039-87-7) is a quinazoline derivative with significant potential in pharmaceutical and materials science research. This compound, characterized by its bromine and chlorine substituents, has garnered attention due to its unique structural features and reactivity. Researchers are increasingly exploring its applications in drug discovery, particularly as a building block for kinase inhibitors and other bioactive molecules. The presence of both halogen atoms and a hydroxyl group in its structure makes it a versatile intermediate for further chemical modifications.

In recent years, the demand for heterocyclic compounds like 7-Bromo-2,5-dichloroquinazolin-8-ol has surged, driven by advancements in medicinal chemistry and organic synthesis. A growing number of studies highlight its role in the development of targeted therapies, especially in oncology and inflammation research. The compound's CAS number 953039-87-7 is frequently searched in academic databases, reflecting its relevance in cutting-edge scientific investigations. Its molecular weight and solubility properties are also critical parameters for researchers optimizing synthetic routes.

One of the most discussed topics in chemical research today is the design of multi-functional intermediates, and 7-Bromo-2,5-dichloroquinazolin-8-ol fits this trend perfectly. Its ability to undergo cross-coupling reactions and nucleophilic substitutions makes it valuable for constructing complex molecular architectures. Additionally, its fluorescence properties have sparked interest in materials science, where it is being studied for potential use in organic electronics and sensors.

From an SEO perspective, queries such as "synthesis of 7-Bromo-2,5-dichloroquinazolin-8-ol" and "CAS 953039-87-7 suppliers" are trending among chemists and procurement specialists. The compound's safety data and handling precautions are also frequently searched, underscoring the need for accurate technical documentation. As a research chemical, it is essential to emphasize its non-hazardous classification under standard laboratory conditions, aligning with global chemical safety standards.

The future of 7-Bromo-2,5-dichloroquinazolin-8-ol lies in its adaptability to emerging green chemistry protocols. Researchers are investigating catalyst-free reactions and solvent-free conditions to enhance its synthetic utility while minimizing environmental impact. Its role in high-throughput screening libraries further solidifies its position as a key player in drug development pipelines. With ongoing studies exploring its structure-activity relationships, this compound is poised to contribute to breakthroughs in precision medicine.

In summary, 7-Bromo-2,5-dichloroquinazolin-8-ol (CAS No. 953039-87-7) represents a critical tool for modern chemical innovation. Its multifaceted applications, from pharmaceutical intermediates to functional materials, highlight its importance across scientific disciplines. As interest in quinazoline chemistry continues to grow, this compound will remain at the forefront of research and development efforts worldwide.

• 953040-03-4(5-Bromo-2-chloroquinazolin-8-ol)
• 953039-17-3(7-Bromo-2-chloroquinazolin-8-ol)
• 1036755-87-9(6-Bromo-2,5-dichloro-8-methoxyquinazoline)
• 2570190-10-0(8-Quinazolinol, 5,7-dibromo-2-chloro-)
• 1594537-70-8(5-bromo-2,4-dichloro-8-methoxy-quinazoline)
• 1036757-57-9(6-Bromo-2-chloroquinazolin-8-ol)
• 953039-88-8(7-Bromo-2,5-dichloro-8-methoxyquinazoline)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)